Proceedings.

Insolvency cases across Canada

41 tracked cases · 123,449 filings · CCAA, receiverships, NOIs, proposals, and bankruptcies

Clear filters
1–41 of 41 · sorted by last activity
CaseTypeStatusProvinceCommencedLast activity ▲Stated liab.Lead firmFilings
Qbiogene inc.CCAAClosedQuebec22 Jul 200420 Dec 2010—Richter18
PharmEng International Inc. and Keata et alNOIClosedOntario30 Apr 20093 May 2011—GlassRatner45
Origin Biomed Inc.Receivership (court-appointed)ActiveNova Scotia7 Apr 20154 Jun 2015—Doane Grant Thornton3
ConjuChem Biotechnologies Inc.CCAAClosedQuebec26 Feb 201014 Jul 2015—Richter34
Graceway Canada CompanyReceivership (court-appointed)ClosedOntario4 Oct 201129 Aug 2016—Richter34
Old API Wind-Down Ltd. (formerly Aralez Pharmaceuticals Inc.)CCAAClosedOntario10 Aug 201820 Jun 2019—Richter88
Fortuna Fix inc.NOIActiveQuebec20 Mar 202014 Apr 2020Deloitte6
Cyon Therapeutics Inc.BankruptcyClosedBritish Columbia21 Dec 20178 Apr 2021—MNP6
Phenomenome Discoveries Inc. & Phenomenome Laboratory Services Inc.Receivership (court-appointed)ClosedSaskatchewan26 Nov 201529 Apr 2021FTI49
Pharm Canada Inc.Receivership (private)ClosedOntario29 Mar 202230 Mar 2022—MNP1
Pharmetics (2011) Inc.BankruptcyClosedQuebec16 Feb 201831 Oct 2022—Richter12
IMV Inc., Immunovaccine Technologies Inc. and IMV USA Inc.CCAAClosedNova Scotia1 May 20235 Jan 2024—FTI92
Tanta Pharmaceuticals Inc.NOIActiveOntario13 Apr 202316 Feb 2024B. Riley Farber13
Medipure Pharmaceuticals Inc. and Medipure Holdings Inc.CCAAClosedBritish Columbia19 Aug 202211 Apr 2024—Deloitte38
Antibe Therapeutics Inc.CCAAClosedOntario9 Apr 202413 May 2024—Deloitte21
Halucenex Life Sciences IncorporatedBankruptcyActiveNova Scotia28 May 20243 Jun 2024BDO3
ACERUS PHARMACEUTICALS CORPORATION, ACERUS BIOPHARMA INC., ACERUS LABS INC. AND ACERUS PHARMACEUTICALS USA, LLC.CCAAClosed—26 Jan 202315 Jul 2024—EY65
Naeja Pharmaceuticals Inc.Receivership (court-appointed)ClosedAlberta13 May 201621 Oct 2024—Deloitte5
Clairvoyant Therapeutics Inc.BankruptcyActiveBritish Columbia31 Oct 202414 Nov 2024MNP3
Intellipharmaceutics International Inc. et alBankruptcyActiveOntario31 Oct 202418 Nov 2024KPMG6
9525-4223 Québec Inc. and 9525-4231 Québec Inc. (formerly IntelGenx)CCAAClosedQuebec17 May 202416 Jan 2025EY40
Endoceutics inc. et alCCAAClosedQuebec26 Sep 20226 Feb 2025EY77
Angiochem IncProposalActiveQuebec19 Dec 202410 Mar 2025PwC13
Softab Technologies Inc.Receivership (court-appointed)ActiveOntario15 Jul 202518 Sep 2025—BDO4
Contract Pharmaceuticals LimitedCCAAClosedOntario15 Dec 202331 Oct 2025—KSV55
Paladin Labs Canadian Holding Inc. and Paladin Labs Inc.Foreign recognition (CCAA)ClosedOntario—29 Dec 2025——56
KalGene Inc.BankruptcyActiveQuebec29 Apr 202619 May 2026KPMG3
Purdue Pharma LPForeign recognition (CCAA)ClosedOntario19 Sep 201922 May 2026——183
Starpax Biopharma Inc.CCAAClosedQuebec12 Sep 20253 Jun 2026Raymond Chabot27
VBI GroupCCAAClosedOntario30 Jul 202417 Jun 2026EY52
Starpax Biopharma Inc. (Bankruptcy)BankruptcyActiveQuebec23 Jun 202623 Jun 2026Raymond Chabot1
1001138302 Ontario Inc.Receivership (court-appointed)ActiveOntario22 Apr 20247 Jul 2026FTI31
Impopharma IncNOIClosedOntario25 Jul 201820 Jul 2026—Richter20
Novelion Therapeutics Inc.Winding-up (provincial)ClosedBritish Columbia9 Jan 202024 Jul 2026—Alvarez & Marsal43
Immune BioSolutions Inc.NOIActiveQuebec3 Jul 202614 Sep 2026—MNP6
Laurent Pharmaceuticals inc.BankruptcyActiveQuebec11 Sep 202617 Sep 2026Raymond Chabot1
Valeo Pharma Inc. GroupCCAAActiveQuebec1 Oct 202429 Sep 2026EY65
Allumiqs Solutions inc. and Allumiqs CorporationNOIActiveNova Scotia3 Jul 202630 Sep 2026MNP15
IGY Immune Technologies & Life Sciences Inc., IGY Life Sciences Manufacturing Inc. and IGY Life Sciences USA, Inc.Receivership (court-appointed)ActiveAlberta17 Apr 20265 Oct 2026Alvarez & Marsal10
BCE Pharma Inc.Type unspecifiedClosed————MNP0
ODF Pharma Inc.Type unspecifiedClosed————MNP0

Facts and summaries are extracted automatically from the court filings linked on each page; the filings remain the authoritative record. Suggested corrections are reviewed against the source filings.